Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a processed pseudogene of the gene encoding Diphosphoinositol polyphosphate phosphohydrolase 2, commonly known as NUDT4 or DIPP2. Pseudogenes are nonfunctional segments of DNA that resemble functional genes either as processed (lacking introns and often derived from reverse-transcribed mRNA reintegration) or unprocessed duplicates. The ENSG00000267689 locus lacks protein-coding capacity, so it does not contribute to diphosphoinositol polyphosphate metabolism or molecular switching activity in cells. Its existence is a product of genome evolution, without evidence of biological activity, interaction with drugs, or clinical utility[7][6][4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diphosphoinositol polyphosphate phosphohydrolase 2, pseudogene.